Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection

US Patent 8337828 · Granted Dec 25, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Thymosin alpha 1 for use in treatment of cystic fibrosis2024
Thymosin alpha 1 for use in treatment of cystic fibrosis2024
Thymosin alpha 1 for use in treatment of cystic fibrosis2022
Thymosin alpha 1 for use in treatment of cystic fibrosis2022
Indole-3-aldehyde for treating dysreactive immune disorders2020
Thymosin alpha 1 for use in treatment of cystic fibrosis2019
Thymosin alpha 1 for use in treatment of cystic fibrosis2019
Monoclonal antibody to human line-1 ORF2 protein and method for early detection 2019
Anti tumoral immunogenic peptides and vaccine thereof2015
Treatment of retroviral reservoirs exploiting oxidative stress2014
Use of IL-23 antagonists for treatment of infection2013
Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of in2013